Plug and play nanocage platform for creating new vaccines

PROTEIX plans to launch a project to revolutionize vaccine development for public use and veterinary applications using its plug-and-play nanocage platform. Using our safe platform technology, we will combine building blocks — antigens, immunogens, and adjuvants — to construct nanocages decorated with antigens that act as efficacious and durable vaccines. The scalability and simple manufacturing process to make these nanocage vaccines makes our platform suitable for public health and veterinary use.